In vitro and in vivo activities of leukotriene B4-loaded biodegradable microspheres
- 1 February 2007
- journal article
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 83 (1-2) , 121-129
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidaseBlood, 2005
- Release of Anti‐HIV Mediators after Administration of Leukotriene B4to HumansThe Journal of Infectious Diseases, 2004
- Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissuesNature Immunology, 2003
- Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosisGene Therapy, 2003
- Tumour necrosis factor‐alpha and leukotriene B4 mediate the neutrophil migration in immune inflammationBritish Journal of Pharmacology, 2001
- Epstein–Barr virus primes human polymorphonuclear leucocytes for the biosynthesis of leukotriene B4Clinical and Experimental Immunology, 2001
- Controlled release of β-estradiol from PLAGA microparticles:Journal of Controlled Release, 2000
- Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D,L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behaviorJournal of Controlled Release, 1993
- Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to ratsBiomaterials, 1992
- Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration “in vivo” by indirect mechanismsInflammation Research, 1990